Precigen (NASDAQ: PGEN) net income
Precigen reported a net loss of $250.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $126.2m. Earnings per share were −$1.37.
Precigen's best year of the last 10 was fiscal 2022. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$250.6m | — | −2,588.2% | −$1.37 |
| 2024 | −$126.2m | — | −3,216.2% | −$0.47 |
| 2023 | −$95.9m | −438.7% | −1,540.6% | −$0.39 |
| 2022 | $28.3m | — | 105.2% | $0.14 |
| 2021 | −$92.2m | — | −646.0% | −$0.47 |
| 2020 | −$170.5m | — | −533.0% | −$1.02 |
| 2019 | −$322.3m | — | −355.3% | −$2.09 |
| 2018 | −$509.3m | — | −336.9% | — |
| 2017 | −$117.0m | — | −53.3% | — |
| 2016 | −$186.6m | — | −97.7% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Precigen net income compared with its sector
By net income for its latest fiscal year, Precigen ranks 435th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Precigen, −2,588.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 433rd | Sana Biotechnology | −$244.2m | — |
| 434th | Tempus AI | −$245.0m | −19.3% |
| 435th | Precigen | −$250.6m | −2,588.2% |
| 436th | Celldex Therapeutics | −$258.8m | −16,748.0% |
| 437th | Brookdale Senior Living | −$262.7m | −8.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Precigen
- How much did Precigen earn in fiscal 2025?
- Precigen reported a net loss of $250.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $126.2m.
- What are the earnings per share of Precigen?
- They were −$1.37 in fiscal 2025, compared with −$0.47 in fiscal 2024.
- What was the most profitable year for Precigen?
- Of its last 10 fiscal years, fiscal 2022, with $28.3m.
- Where does Precigen rank in its sector by net income?
- It ranks 435th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Precigen come from?
- From the annual report (Form 10-K) that Precigen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Precigen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Precigen: the Precigen page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.